Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Abacavir 600mg / Lamivudine 300mg tablets |
BNF code | 0503010Z0AAAAAA |
Virtual Therapeutic Moiety | Abacavir + Lamivudine |
Date identifier became valid | 27 May 2021 |
Previous product identifier | 413382007 |
Basis of preferred name | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Abacavir |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 600.000 |
Strength value numerator unit | mg |
Virtual Product Ingredient | |
Ingredient | Lamivudine |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 300.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tablet.oral |
Dose Form | |
Formulation | Oral tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Abacavir 600mg / Lamivudine 300mg tablets (Amarox Ltd) | |
Abacavir 600mg / Lamivudine 300mg tablets (Dr Reddy's Laboratories (UK) Ltd) | |
Abacavir 600mg / Lamivudine 300mg tablets (Macleods Pharma UK Ltd) | |
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharma UK Ltd) | |
Kivexa 600mg/300mg tablets (ViiV Healthcare UK Ltd) | |
Virtual Medicinal Product Packs | |
Abacavir 600mg / Lamivudine 300mg tablets 30 tablet |
dm+d data retrieved from TRUD: release NHSBSA_1.2.0_20250113000001, imported on 14th January 2025 at 04:06:47.